News
New malaria vaccine shows promise
BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7183.557 (Published 27 February 1999) Cite this as: BMJ 1999;318:557- Deborah Josefson,
- San Francisco
An experimental malaria vaccine designed to protect the host from each stage of the parasite's life cycle has shown promise in animal trials (Proceedings of the National Academy of Sciences 1999;96:1615-20).
Researchers from the US Centers for Disease Control and Prevention in Atlanta, Georgia, have created a recombinant, multivalent vaccine against Plasmodium falciparum, the deadliest malaria parasite. This vaccine differs from previous vaccines because it …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.